Evidence map›Paper›PMID 36653550›Full record

ReviewNature reviews. Genetics2023

Navigating the pitfalls of mapping DNA and RNA modifications.

Yimeng Kong, Edward A Mead, Gang Fang

Abstract readReview
In one paragraph

Review in Nature reviews. Genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Optimizing C14120-based LNPs forMolecular therapy. Nucleic acids · 2026
    Article
  10. Article
  11. Targeting intracellular mRNA mJournal of advanced research · 2026
    Review
  12. Seven wonders of RNA modification biology.RNA (New York, N.Y.) · 2026
    Review
  13. Article
  14. Article
  15. 8-Oxoguanine: A Lesion, an Epigenetic Mark, or a Molecular Signal?International journal of molecular sciences · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yimeng KongDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Edward A MeadDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-4588-8096
Gang FangDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. gang.fang@mssm.edu.ORCID 0000-0002-2462-9124

Funding

Conduits: Mount Sinai Health System Translational Science HubUL1TR004419 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rosalind J Wright · 2022 to 2026
$46.4M
High Resolution Characterization of Bacterial Epigenomes and MicrobiomeR35GM139655 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Gang Fang · 2021 to 2026
$4.9M
Direct Determination of Multiple Specific Forms of DNA Chemical Modifications in Human GenomeR01HG011095 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FANG, GANG · 2021 to 2023
$2.2M
NCATS NIH HHS UL1 TR004419NHGRI NIH HHS R01 HG011095NIGMS NIH HHS R35 GM139655
6 · The paper itself

Abstract

Chemical modifications to nucleic acids occur across the kingdoms of life and carry important regulatory information. Reliable high-resolution mapping of these modifications is the foundation of functional and mechanistic studies, and recent methodological advances based on next-generation sequencing and long-read sequencing platforms are critical to achieving this aim. However, mapping technologies may have limitations that sometimes lead to inconsistent results. Some of these limitations are technical in nature and specific to certain types of technology. Here, however, we focus on common (yet not always widely recognized) pitfalls that are shared among frequently used mapping technologies and discuss strategies to help technology developers and users mitigate their effects. Although the emphasis is primarily on DNA modifications, RNA modifications are also discussed.

Indexed as

DNARNAHigh-Throughput Nucleotide SequencingSequence Analysis, DNADNARNA

Identifiers

PMID36653550
PMCPMC10722219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.